Approval · Notice of Compliance 2548 · 2001
RAMACE: Notice of Compliance 2548
Issued July 19, 2001
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2548
- Date
- July 19, 2001
- Company
- Astrazeneca Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- New indication: management of patients at increased risk of cardiovascular events
- Therapeutic class
- Angiotensin-converting enzyme inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RAMACE | Not yet assigned | — |